Cargando…

Multi-Parametric MRI at 14T for Muscular Dystrophy Mice Treated with AAV Vector-Mediated Gene Therapy

The objective of this study was to investigate the efficacy of using quantitative magnetic resonance imaging (MRI) as a non-invasive tool for the monitoring of gene therapy for muscular dystrophy. The clinical investigations for this family of diseases often involve surgical biopsy which limits the...

Descripción completa

Detalles Bibliográficos
Autores principales: Park, Joshua, Wicki, Jacqueline, Knoblaugh, Sue E., Chamberlain, Jeffrey S., Lee, Donghoon
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4391935/
https://www.ncbi.nlm.nih.gov/pubmed/25856443
http://dx.doi.org/10.1371/journal.pone.0124914
_version_ 1782365900609945600
author Park, Joshua
Wicki, Jacqueline
Knoblaugh, Sue E.
Chamberlain, Jeffrey S.
Lee, Donghoon
author_facet Park, Joshua
Wicki, Jacqueline
Knoblaugh, Sue E.
Chamberlain, Jeffrey S.
Lee, Donghoon
author_sort Park, Joshua
collection PubMed
description The objective of this study was to investigate the efficacy of using quantitative magnetic resonance imaging (MRI) as a non-invasive tool for the monitoring of gene therapy for muscular dystrophy. The clinical investigations for this family of diseases often involve surgical biopsy which limits the amount of information that can be obtained due to the invasive nature of the procedure. Thus, other non-invasive tools may provide more opportunities for disease assessment and treatment responses. In order to explore this, dystrophic mdx(4cv) mice were systemically treated with a recombinant adeno-associated viral (AAV) vector containing a codon-optimized micro-dystrophin gene. Multi-parametric MRI of T2, magnetization transfer, and diffusion effects alongside 3-D volume measurements were then utilized to monitor disease/treatment progression. Mice were imaged at 10 weeks of age for pre-treatment, then again post-treatment at 8, 16, and 24 week time points. The efficacy of treatment was assessed by physiological assays for improvements in function and quantification of expression. Tissues from the hindlimbs were collected for histological analysis after the final time point for comparison with MRI results. We found that introduction of the micro-dystrophin gene restored some aspects of normal muscle histology and pathology such as decreased necrosis and resistance to contraction-induced injury. T2 relaxation values showed percentage decreases across all muscle types measured (tibialis anterior, gastrocnemius, and soleus) when treated groups were compared to untreated groups. Additionally, the differences between groups were statistically significant for the tibialis anterior as well. The diffusion measurements showed a wider range of percentage changes and less statistical significance while the magnetization transfer effect measurements showed minimal change. MR images displayed hyper-intense regions of muscle that correlated with muscle pathology in histological sections. T2 relaxation, alongside diffusion and magnetization transfer effects provides useful data towards the goal of non-invasively monitoring the treatment of muscular dystrophy.
format Online
Article
Text
id pubmed-4391935
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-43919352015-04-21 Multi-Parametric MRI at 14T for Muscular Dystrophy Mice Treated with AAV Vector-Mediated Gene Therapy Park, Joshua Wicki, Jacqueline Knoblaugh, Sue E. Chamberlain, Jeffrey S. Lee, Donghoon PLoS One Research Article The objective of this study was to investigate the efficacy of using quantitative magnetic resonance imaging (MRI) as a non-invasive tool for the monitoring of gene therapy for muscular dystrophy. The clinical investigations for this family of diseases often involve surgical biopsy which limits the amount of information that can be obtained due to the invasive nature of the procedure. Thus, other non-invasive tools may provide more opportunities for disease assessment and treatment responses. In order to explore this, dystrophic mdx(4cv) mice were systemically treated with a recombinant adeno-associated viral (AAV) vector containing a codon-optimized micro-dystrophin gene. Multi-parametric MRI of T2, magnetization transfer, and diffusion effects alongside 3-D volume measurements were then utilized to monitor disease/treatment progression. Mice were imaged at 10 weeks of age for pre-treatment, then again post-treatment at 8, 16, and 24 week time points. The efficacy of treatment was assessed by physiological assays for improvements in function and quantification of expression. Tissues from the hindlimbs were collected for histological analysis after the final time point for comparison with MRI results. We found that introduction of the micro-dystrophin gene restored some aspects of normal muscle histology and pathology such as decreased necrosis and resistance to contraction-induced injury. T2 relaxation values showed percentage decreases across all muscle types measured (tibialis anterior, gastrocnemius, and soleus) when treated groups were compared to untreated groups. Additionally, the differences between groups were statistically significant for the tibialis anterior as well. The diffusion measurements showed a wider range of percentage changes and less statistical significance while the magnetization transfer effect measurements showed minimal change. MR images displayed hyper-intense regions of muscle that correlated with muscle pathology in histological sections. T2 relaxation, alongside diffusion and magnetization transfer effects provides useful data towards the goal of non-invasively monitoring the treatment of muscular dystrophy. Public Library of Science 2015-04-09 /pmc/articles/PMC4391935/ /pubmed/25856443 http://dx.doi.org/10.1371/journal.pone.0124914 Text en © 2015 Park et al http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited.
spellingShingle Research Article
Park, Joshua
Wicki, Jacqueline
Knoblaugh, Sue E.
Chamberlain, Jeffrey S.
Lee, Donghoon
Multi-Parametric MRI at 14T for Muscular Dystrophy Mice Treated with AAV Vector-Mediated Gene Therapy
title Multi-Parametric MRI at 14T for Muscular Dystrophy Mice Treated with AAV Vector-Mediated Gene Therapy
title_full Multi-Parametric MRI at 14T for Muscular Dystrophy Mice Treated with AAV Vector-Mediated Gene Therapy
title_fullStr Multi-Parametric MRI at 14T for Muscular Dystrophy Mice Treated with AAV Vector-Mediated Gene Therapy
title_full_unstemmed Multi-Parametric MRI at 14T for Muscular Dystrophy Mice Treated with AAV Vector-Mediated Gene Therapy
title_short Multi-Parametric MRI at 14T for Muscular Dystrophy Mice Treated with AAV Vector-Mediated Gene Therapy
title_sort multi-parametric mri at 14t for muscular dystrophy mice treated with aav vector-mediated gene therapy
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4391935/
https://www.ncbi.nlm.nih.gov/pubmed/25856443
http://dx.doi.org/10.1371/journal.pone.0124914
work_keys_str_mv AT parkjoshua multiparametricmriat14tformusculardystrophymicetreatedwithaavvectormediatedgenetherapy
AT wickijacqueline multiparametricmriat14tformusculardystrophymicetreatedwithaavvectormediatedgenetherapy
AT knoblaughsuee multiparametricmriat14tformusculardystrophymicetreatedwithaavvectormediatedgenetherapy
AT chamberlainjeffreys multiparametricmriat14tformusculardystrophymicetreatedwithaavvectormediatedgenetherapy
AT leedonghoon multiparametricmriat14tformusculardystrophymicetreatedwithaavvectormediatedgenetherapy